Maged Shenouda Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Maged Shenouda.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Maged Shenouda. Maged Shenouda is Director in Protea Biosciences Group, Inc. ($PRGB) and CFO in RELMADA THERAPEUTICS, INC. ($RLMD) and Director in RELMADA THERAPEUTICS, INC. ($RLMD) and in AzurRx BioPharma, Inc. ($AZRX) and CHIEF FINANCIAL OFFICER in AzurRx BioPharma, Inc. ($AZRX).
Latest Insider Trading Transactions of Maged Shenouda
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AZRX, PRGB, RLMD
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Option Exercise | M | 3.24 | 10,000 | 32,400 | 70,350 | |
| Mar 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.11 | 2,373 | 83,313 | 2,228 | 4.6 K to 2.2 K (-51.58 %) |
| Mar 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 36.02 | 1,800 | 64,836 | 4,601 | 6.4 K to 4.6 K (-28.12 %) |
| Mar 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.42 | 5,727 | 202,857 | 6,401 | 12.1 K to 6.4 K (-47.22 %) |
| Mar 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.00 | 100 | 3,500 | 12,128 | 12.2 K to 12.1 K (-0.82 %) |
| Mar 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Buy | M | 3.24 | 10,000 | 32,400 | 12,228 | 2.2 K to 12.2 K (+448.83 %) |
| Feb 16 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Option Exercise | M | 3.24 | 1,428 | 4,627 | 83,250 | |
| Feb 16 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.39 | 1,428 | 50,542 | 2,228 | 3.7 K to 2.2 K (-39.06 %) |
| Feb 16 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Buy | M | 3.24 | 1,428 | 4,627 | 3,656 | 2.2 K to 3.7 K (+64.09 %) |
| Feb 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Option Exercise | M | 3.24 | 11,372 | 36,845 | 84,678 | |
| Feb 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.20 | 2,410 | 84,825 | 2,228 | 4.6 K to 2.2 K (-51.96 %) |
| Feb 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.24 | 5,359 | 188,843 | 4,638 | 10 K to 4.6 K (-53.61 %) |
| Feb 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.04 | 3,603 | 126,242 | 9,997 | 13.6 K to 10 K (-26.49 %) |
| Feb 10 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Buy | M | 3.24 | 11,372 | 36,845 | 13,600 | 2.2 K to 13.6 K (+510.41 %) |
| Feb 04 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Option Exercise | M | 3.24 | 3,200 | 10,368 | 96,050 | |
| Feb 04 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.00 | 100 | 3,500 | 2,228 | 2.3 K to 2.2 K (-4.30 %) |
| Feb 04 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.04 | 3,100 | 108,634 | 2,328 | 5.4 K to 2.3 K (-57.11 %) |
| Feb 04 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Buy | M | 3.24 | 3,200 | 10,368 | 5,428 | 2.2 K to 5.4 K (+143.63 %) |
| Jan 29 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Option Exercise | M | 3.24 | 3,000 | 9,720 | 99,250 | |
| Jan 29 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 32.43 | 1,200 | 38,916 | 2,228 | 3.4 K to 2.2 K (-35.01 %) |
| Jan 29 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 31.59 | 1,800 | 56,862 | 3,428 | 5.2 K to 3.4 K (-34.43 %) |
| Jan 29 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Buy | M | 3.24 | 3,000 | 9,720 | 5,228 | 2.2 K to 5.2 K (+134.65 %) |
| Jan 26 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Option Exercise | M | 3.24 | 4,000 | 12,960 | 102,250 | |
| Jan 26 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.16 | 607 | 21,342 | 2,228 | 2.8 K to 2.2 K (-21.41 %) |
| Jan 26 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.27 | 1,280 | 45,146 | 2,835 | 4.1 K to 2.8 K (-31.11 %) |
| Jan 26 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 36.15 | 409 | 14,785 | 4,115 | 4.5 K to 4.1 K (-9.04 %) |
| Jan 26 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Sell | S | 35.41 | 1,704 | 60,339 | 4,524 | 6.2 K to 4.5 K (-27.36 %) |
| Jan 26 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Buy | M | 324.00 | 4,000 | 1,296,000 | 6,228 | 2.2 K to 6.2 K (+179.53 %) |
| Jan 11 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Option Exercise | A | 33.43 | 127,500 | 4,262,325 | 127,500 | |
| Jan 11 2021 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | CFO | Option Exercise | A | 33.43 | 127,500 | 4,262,325 | 127,500 | |
| Dec 23 2019 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | Director | Option Exercise | A | 43.47 | 120,000 | 5,216,400 | 120,000 | |
| Oct 21 2019 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | Director | Buy | P | 23.00 | 978 | 22,494 | 2,228 | 1.3 K to 2.2 K (+78.24 %) |
| Jul 30 2019 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | Director | Option Exercise | A | 2.20 | 500,000 | 1,100,000 | 500,000 | |
| Jan 02 2019 | AZRX | AzurRx BioPharma, ... | Shenouda Maged | CHIEF FINANCIAL OFF ... | Buy | P | 1.31 | 20,000 | 26,214 | 62,500 | 42.5 K to 62.5 K (+47.06 %) |
| Dec 20 2018 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | Director | Option Exercise | A | 1.15 | 450,000 | 517,500 | 450,000 | |
| Jul 16 2018 | AZRX | AzurRx BioPharma, ... | Shenouda Maged | CHIEF FINANCIAL OFF ... | Option Exercise | A | 3.04 | 100,000 | 304,000 | 100,000 | |
| Oct 23 2017 | AZRX | AzurRx BioPharma, ... | Shenouda Maged | CHIEF FINANCIAL OFF ... | Grant | A | 0.00 | 22,500 | 0 | 42,500 | 20 K to 42.5 K (+112.50 %) |
| Oct 23 2017 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | Director | Option Exercise | A | 0.81 | 425,000 | 344,250 | 425,000 | |
| Sep 27 2017 | AZRX | AzurRx BioPharma, ... | Shenouda Maged | CHIEF FINANCIAL OFF ... | Option Exercise | A | 4.39 | 100,000 | 439,000 | 100,000 | |
| Feb 07 2017 | AZRX | AzurRx BioPharma, ... | Shenouda Maged | Option Exercise | A | 4.48 | 30,000 | 134,400 | 30,000 | ||
| Jan 07 2016 | PRGB | Protea Biosciences ... | Shenouda Maged | Director | Option Exercise | A | 0.25 | 66,667 | 16,667 | 66,667 | |
| Jan 07 2016 | PRGB | Protea Biosciences ... | Shenouda Maged | Director | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
| Dec 17 2015 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | Director | Buy | P | 3.00 | 759 | 2,277 | 5,000 | 4.2 K to 5 K (+17.90 %) |
| Dec 17 2015 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | Director | Buy | P | 2.99 | 241 | 721 | 4,241 | 4 K to 4.2 K (+6.03 %) |
| Dec 17 2015 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | Director | Buy | P | 2.98 | 2,000 | 5,960 | 4,000 | 2 K to 4 K (+100.00 %) |
| Dec 16 2015 | RLMD | RELMADA THERAPEUTI ... | Shenouda Maged | Director | Buy | P | 2.89 | 2,000 | 5,780 | 2,000 | 0 to 2 K |
Page: 1